| Literature DB >> 34761211 |
I Idris1, A W Awotidebe2, N B Mukhtar2, R N Ativie3, J M Nuhu2, I C Muhammad4, A S Danbatta5, R A Adedoyin6, J Mohammed2.
Abstract
BACKGROUND: Management of patients in intensive care units (ICUs) needs staff with a recommended level of expertise and experience owing to the life-threatening nature of illnesses, injuries and complications that these patients present with. There are no specific guidelines governing physiotherapy practice in ICUs in Nigeria. Hence, there is a need to have expert consensus on the minimum clinical standard of practice for physiotherapists working in ICUs as a first step to proposing/developing guidelines in the future.Entities:
Keywords: Delphi technique; critical care physiotherapy; expert consensus; standards of practice
Year: 2021 PMID: 34761211 PMCID: PMC8573816 DOI: 10.7196/AJTCCM.2021.v27i3.137
Source DB: PubMed Journal: Afr J Thorac Crit Care Med ISSN: 2617-0191
Fig. 1Flowchart of the recruitment and Delphi process.
Demographics of the experts that participated in the Delphi study (n=26)
|
|
|
|
| 40.8 (8.6) |
|
| |
| Male | 16 (61.5) |
| Female | 10 (38.5) |
|
| |
| University hospitals | 18 (69.2) |
| University academics | 2 (7.7) |
| Medical centre | 1 (3.8) |
| Specialist hospitals | 3 (11.6) |
| Private hospitals | 2 (7.7) |
|
| |
| 5 - 10 | 10 (38.5) |
| 10 - 15 | 5 (19.2) |
| 15 - 20 | 6 (23.1) |
| >20 | 5 (19.2) |
|
| |
| <2 | 17 (85.0) |
| 2 - 6 | 3 (15.0) |
ICU = intensive care unit
SD = standard deviation
*Unless otherwise specified
Assessment items determined as essentials (consensus >70% ‘essential’)
|
|
|
|
|
|
| |||
| Body temperature | 100 | ||
| Heart rate | 100 | ||
| Blood pressure | 100 | ||
| Basic ECGs, SpO2/pulse oximetry | 100 | ||
| End tidal carbon dioxide | 96.2 | ||
| Fluid intake and output | 100 | ||
|
| |||
| Oxygen therapy devices | 100 | ||
| Endotracheal tubes and tracheostomy | 92.3 | ||
| Central venous catheters | 88.5 | ||
| Arterial lines | 96.2 | ||
| Venous blood gas interpretation (including SvO2) | 61.5† | 88 | |
| Intercostal catheters | 84.6 | ||
| Wound drains | 80.8 | ||
| Indwelling urinary catheter | 100 | ||
| Nasogastric tubes | 100 | ||
|
| |||
| Haemoglobin | 100 | ||
| Platelets, APTT, INR | 92.3 | ||
| White cell count | 88.5 | ||
| Blood glucose levels | 100 | ||
|
| |||
| Vasopressors/inotropes | 84.6 | ||
| Basic electrolytes | 100 | ||
| Anti-hypertensives | 92.3 | ||
| Anti-arrhythmia | 100 | ||
| Sedation and neuromuscular paralysing agents | 61.5* | 92 | |
| Bronchodilators | 92.3 | ||
| Mucolytics | 69.3* | 92 | |
|
| |||
| Chest radiographs | 96.2 | ||
|
| |||
| Intra-cranial and cerebral perfusion pressure monitors | 96.2 | ||
| An ability to interpret an assessment of sedation levels (e.g. Ramsey Sedation Scale, Riker, Richmond-Agitation Sedation Scale) | 84.6 | ||
| An ability to perform a neurological examination of motor and sensory functions (e.g. light touch, pain) e.g. ASIA score | 100 | ||
| An ability to interpret a Glasgow Coma Score | 100 | ||
|
| |||
| Observation of respiratory rate | 100 | ||
| Patterns of breathing | 96.2 | ||
| Palpate the chest wall | 100 | ||
| Auscultation | 100 | ||
|
| |||
| CPAP | 92.3 | ||
| PEEP/EPAP | 96.2 | ||
| SIMV (volume)/(pressure) | 69.2* | 92 | |
| BiLevel | 46.2* | 88 | |
| PS/IPAP | 92.3 | ||
|
| |||
| Respiratory rate | 96 | ||
| Peak inspiratory pressure | 92.3 | ||
| Inspiration: expiration ratio | 100 | ||
| Tidal volume | 100 | ||
| Breath types (spontaneous, mandatory, assisted) | 100 | ||
| The levels of FiO2 | 100 | ||
| The levels of PEEP | 100 | ||
| The levels of PS | 88.5 | ||
|
| |||
| Assess the effectiveness/quality of a patient’s cough | 100 | ||
| Record and interpret observations from physical clinical examination | |||
|
| |||
| pH | 100 | ||
| PaCO2 | 100 | ||
| PaO2, SpO2, SaO2 | 100 | ||
| HCO3 | 100 | ||
| Base excess | 92.3 | ||
| P50 | 65.4† | 92 | |
|
| |||
| Manual muscle testing | 69.2* | 84 | |
| Range of motion | 84.6 | ||
| Deep-vein thrombosis screening | 100 | ||
| Peripheral oedema | 92.3 | ||
|
| |||
| Extra-corporeal membrane oxygenation | 69.2* | 80 | |
| Intracranial pressure monitors and extra-ventricular drains | 96.2 | ||
|
| |||
| Advanced ECGs | 80.8 | ||
| Nutritional status including feed administration, volume and type | 61.5* | 100 | |
|
| |||
| Haematocrit | 96.2 | ||
| Creatinine kinase | 96.2 | ||
| Neutrophil count | 92.3 | ||
| Albumin | 92.3 | ||
| Liver function tests | 88.5 | ||
|
| |||
| Calcium channel blockers, cerebral diuretics, hypertonic saline | 96.2 | ||
| Nitric oxide | 92.3 | ||
|
| |||
| Skeletal X-rays | 96.2 | ||
| CT – Brain | 100 | ||
| CT – Chest | 100 | ||
| CT – Spine | 100 | ||
| MRI – Brain | 100 | ||
| MRI – Spine | 96.2 | ||
| MRI – Chest | 100 | ||
| Ultrasound – Chest | 96.2 | ||
|
| |||
| Electroencephalograms | 88.5 | ||
| An ability to perform a Glasgow Coma Score | 100 | ||
| An ability to perform an assessment of sedation levels | 100 | ||
| An ability to interpret an assessment of cranial nerve function | 96.2 | ||
|
| |||
| High frequency oscillatory ventilation | 88.5 | ||
|
| |||
| Static and/or dynamic lung compliance measurements | 92.4 | ||
| Upper and lower inflection points of P-V curves | 92.4 | ||
| Maximum inspiratory pressure measurements | 92.4 | ||
| Maximum expiratory pressure measurements | 88.5 | ||
|
| |||
| Assess the effectiveness/quality of a patient’s cough Record and interpret observations from physical clinical examination | 100 | ||
| Perform respiratory function tests (e.g. for measurements of FEV1, FVC, PEF) | 100 | ||
| Perform and interpret percussion note | 96.2 | ||
| Measure peak cough flow on or off mechanical ventilation | 84.6 | ||
| Measure peak inspiratory flow rate: Peak Expiratory Flow | 80.8 | ||
| Perform a spontaneous breathing trial | 96 | ||
| Interpret the rapid shallow breathing index | 80.8 | ||
| Perform a swallow assessment | 84.6 | ||
|
| |||
| PaO2/FiO2 ratio | 100 | ||
| A-a gradient | 61.6* | 96 | |
| Oxygen content (CaO2) | 88.5 | ||
| Venous blood gas interpretation (including SvO2) | 69.2* | 88 | |
|
| |||
| Dynamometry | 88.5 | ||
| Objective measures of physical function | 100 | ||
| Perform and Interpret Chelsea Critical Care Physical Assessment Tool | 92.3 | ||
| Objective measures of cardiopulmonary exercise tolerance | 100 | ||
| Objective measures of quality of life | 84.6 | ||
|
| |||
| Positive pressure devices for airway clearance (e.g. AstraPEP, PariPEP, TheraPEP, or oscillating expiratory pressure devices like Acapella, Flutter) | 96.2 | ||
| Periodic/intermittent CPAP (non-invasive via mask) including initiation and titration of NIV/BiPAP – for Type I or Type II respiratory failure, initiation and titration of e.g. COPD exacerbation with hypercapnia | 92.3 | ||
| NIV/BiPAP – intermittent, short term applications during physiotherapy to assist secretion mobilisation techniques or lung recruitment including initiation and titration of assisted coughing - subcostal thrusts for spinal cord injuries | 57.7* | 84 | |
| Ventilator hyperinflation via an endotracheal tube or tracheostomy | 46.2* | 92 | |
|
| |||
| Titration of inotropes to achieve physiotherapy goals | 82.6 | ||
|
| |||
| Of key literature that guides evidence-based physiotherapy practice in critical care settings | 96.2 | ||
|
| |||
| Central venous pressure | 100 | ||
|
| |||
| Renal function tests e.g. urea and creatinine | 100 | ||
| Sputum cultures | 96.2 | ||
|
| |||
| Determine the appropriateness of a patient for extubation | 82.6 | ||
| Determine the appropriateness of a patient for tracheostomy decannulation | 82.6 |
ECG = electrocardiogram; SpO2 = oxygen saturation; SvO2 = mixed venous oxygen saturation
APTT = activated partial thromboplastin time; INR = international normalised ratio; CPAP = continuous positive airway pressure
PEEP/EPAP = positive end-expiratory pressure; SIMV = synchronised intermittent mandatory ventilation; PS = pressure support
IPAP = inspiratory positive airway pressure; FiO2 = fraction of inspired oxygen; PaCO2 = partial pressure of CO2
PaO2 = partial pressure of O2; HCO3 = bicarbonate; P50 = oxygen tension at which haemoglobin is 50% saturated
CT = computed tomography; MRI = magnetic resonance imaging; FEV1 = forced expiratory volume in one second
FVC = forced vital capacity; PEF = peak expiratory flow
*Consensus not reached (>70%) after considering the scored of ‘unsure’
†Consensus not reached (>70%)
Condition items determined as ‘essential’ (consensus >70%)
|
|
|
|
|
|
| |||
| Respiratory failure types I and II | 100 | ||
| Community acquired/nosocomial/hospital-acquired pneumonia | 100 | ||
| Pleural effusion | 100 | ||
| Obstructive respiratory disease | 100 | ||
| Restrictive respiratory disease | 100 | ||
| Suppurative lung diseases | 96.2 | ||
| Acute lung injury/acute respiratory distress syndrome | 100 | ||
| Acute coronary syndrome | 96.2 | ||
| Shock (cardiogenic) | 100 | ||
| Heart failure | 100 | ||
| Post-abdominal surgery | 96.2 | ||
| Renal failure: acute and chronic | 96.2 | ||
| Immunocompromise | 92.3 | ||
| Systemic inflammatory response syndrome | 96.2 | ||
| Shock (septic) | 100 | ||
| Multi-organ failure | 100 | ||
| ICU-acquired weakness | 100 | ||
| Guillain-Barre Syndrome | 68.2* | 68 | 87.5 |
| Thromboembolic disease | 96.2 | ||
| Intracerebral haemorrhage/Subarachnoid haemorrhage | 100 | ||
| Traumatic brain injury | 100 | ||
| Chest trauma | 100 | ||
| Spinal cord injury | 96.2 | ||
| Neuromuscular disease | 96.2 | ||
|
| |||
| Post-cardiac surgery | 100 | ||
| Post-thoracic surgery | 100 | ||
| Pancreatitis | 88.5 | ||
| Metabolic/electrolyte disturbances | 96.2 | ||
| Fat embolism | 88.5 | ||
| Brain death and organ procurement | 76.9 | ||
| Multi-trauma | 96.2 | ||
| Sleep-disordered breathing (e.g. obstructive sleep apnoea, hypoventilation) | 88.5 | ||
|
| |||
| extubation | 82.6 | ||
| tracheostomy decannulation | 82.6 | ||
|
| |||
| Hepatitis | 69.3* | 88 | |
| Organ transplantation | 92.3 | ||
| Burns | 100 |
*Consensus not reached (>70%) after considering the scored of ‘unsure.’
Treatment items determined as ‘essential’ (consensus >70%)
|
|
|
|
|
|
| |||
| Oxygen therapy including initiation and titration of oxygen therapy | 92.3 | ||
| Humidification | 88.5 | ||
| Active cycle of breathing technique | 96.2 | ||
| Manual airway clearance techniques – percussion, vibration, chest shaking | 100 | ||
| Intermittent positive pressure breathing | 96.2 | ||
| Mechanical insufflation-exsufflation | 84.6 | ||
| Supported coughing | 92.3 | ||
| Directed coughing/instructing the patient to cough effectively | 96.2 | ||
| Assisted coughing – chest wall | 96.2 | ||
| Cough stimulation – oropharyngeal catheter stimulation | 96.2 | ||
| Manual hyperinflation via an endotracheal tube or tracheostomy | 92.3 | ||
| Nasopharyngeal airway suctioning, including insertion of NP airway | 96.2 | ||
| Oropharyngeal airway suctioning, including insertion of OP airway | 88.5 | ||
| Suction via a tracheal tube (ETT, tracheostomy, mini-tracheostomy) | 100 | ||
| Instillation of normal saline into the endotracheal tube | 88.5 | ||
| Patient positioning for respiratory care – including use of side lie, sitting upright, postural drainage (modified or head down tilt) | 100 | ||
| Patient positioning for prevention of pressure ulcers, management of tone, maintenance of musculoskeletal function | 100 | ||
| Mobilisation of non-ventilated patient | 100 | ||
| Mobilisation of ventilated patient | 96.2 | ||
| Bed exercises | 96.2 | ||
| Nasal high flow | 88.5 | ||
| Feldenkreis | 61.5† | 68 | 87.5 |
|
| |||
| Titration of analgesia to achieve physiotherapy goals | 53.8* | 68 | 82.6 |
|
| |||
| Assist-control | 100 | ||
| Airway pressure release ventilation | 96.2 | ||
| Weaning protocols | 100 | ||
|
| |||
| Interpret respiratory function tests (e.g. for measurements of FEV1, FVC, PEF) | 100 | ||
|
| |||
| Lactate | 96.2 | ||
|
| |||
| Implanted or external pacemakers and determine presence of pacing on ECG | 92.3 | ||
|
| |||
| Ability to assess tone (e.g. utilising a modified Ashworth scale) and reflexes | 96.2 | ||
|
| |||
| Glottal stacking (frog breathing) | 46.2* | 100 | |
| Other breathing techniques | 100 | ||
| Autogenic drainage | 88.5 | ||
| NIV/BiPAP - for use during exercise or mobilisation including initiation and titration | 60* | 84 | |
| Cough stimulation - tracheal rub | 96.2 | ||
| Recruitment maneuvers, e.g. staircase | 92.3 | ||
| Bronchial lavage | 80.8 | ||
| Assisting bronchoscopy via delivery of secretion | 88.5 | ||
| Mobilisation techniques during the procedure | 96.2 | ||
| Patient prone positioning in severe respiratory | 84.6 | ||
| Failure/acute lung injury | 96.2 | ||
| Inspiratory muscle training | 100 | ||
| Splinting and/or casting for the upper limbs and lower limbs | 100 | ||
| Collars | 92.3 | ||
| Braces | 96.2 | ||
| Treadmill, cycle ergometry or stationary bike, additional rehabilitation techniques (e.g. hydrotherapy, Wii) | 96.2 | ||
|
| |||
| Non-invasive ventilation | 69.3* | 92 |
FEV1 = forced expiratory volume in one second
FVC = forced vital capacity
PEF = peak expiratory flow
*Consensus not reached (>70%) after considering the scored of ‘unsure’
†Consensus not reached (>70%)
Items not reaching any consensus
|
|
|
|
|
|
| |||
| Haemofiltration | 61.5* | 64 | 66.7 |
| Intra-aortic balloon pump | 69.2† | 64 | 66.7 |
| Sengstaken-Blakemore/Minnesota tubes | 60† | 48 | 50 |
|
| |||
| Anion gap | 50† | 60 | 62.5* |
|
| |||
| Pulmonary arterial catheter measurements | 69.2† | 70.8* | 66.7* |
| PiCCO measurements | 50† | 50 | 62.5* |
|
| |||
| Troponin | 53.9* | 66.7 | 66.7* |
| C-reactive protein | 63.7* | 68 | 66.7 |
| Procalcitonin | 57.7* | 68 | 66.7 |
|
| |||
| Prostacyclin (PG12) | 57.1* | 60 | 62.5* |
|
| |||
| Ability to perform a delirium assessment | 65.4* | 52 | 58.3 |
|
| |||
| Bioimpedence testing of body composition | 65.4* | 56 | 66.7 |
|
| |||
| Pancreatitis | 60* | 52 | 56.5 |
|
| |||
| Perform a cuff volume and/or pressure test on an endotracheal tube or tracheostomy | 61.5† | 48 | 45.8 |
|
| |||
| Performing bronchoscopy independently | 57.7 | 44 | 58.3 |
|
| |||
| Intubate a patient | 57.7† | 48 | 50 |
| Extubate a patient | 65.4† | 64 | 54.2 |
| Lead the co-ordination of weaning protocols | 61.5† | 60 | 58.3 |
| Lead the co-ordination of cuff deflation trials | 48† | 48 | 45.8 |
| Lead the co-ordination of speaking valve trials | 50† | 52 | 45.8 |
| Determine the appropriateness of a patient for tracheostomy decannulation | 50† | 56 | 47.8 |
| Decannulate a tracheostomy | 50† | 44 | 54.2 |
| Tracheostomy exchange | 46.2† | 48 | 54.2 |
|
| |||
| Titration of sedation to achieve physiotherapy goals | 46.1* | 64 | 66.6 |
*Consensus not reached (>70%) after considering the scored of ‘unsure’
†Consensus not reached (>70%)